ACE2 deficiency exacerbates obesity-related glomerulopathy through its role in regulating lipid metabolism
Abstract Obesity-related glomerulopathy is a secondary glomerular disease and its incidence has been increased globally in parallel with the obesity epidemic. ORG emerged as a growing cause of end-stage renal disease in recent years. Unbalanced production of adipokines at the adipose tissue as well...
Main Authors: | Yin-Yin Chen, Han Hong, Yu-Ting Lei, Jia Zou, Yi-Ya Yang, Li-Yu He |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2022-09-01
|
Series: | Cell Death Discovery |
Online Access: | https://doi.org/10.1038/s41420-022-01191-2 |
Similar Items
-
Correction: ACE2 deficiency exacerbates obesity-related glomerulopathy through its role in regulating lipid metabolism
by: Yin-Yin Chen, et al.
Published: (2023-10-01) -
Inflammation and Oxidative Stress in Obesity-Related Glomerulopathy
by: Jinhua Tang, et al.
Published: (2012-01-01) -
Viral Glomerulopathy
by: Margaret Deoliveira, et al.
Published: (2023-08-01) -
CD36-Mediated Lipid Accumulation and Activation of NLRP3 Inflammasome Lead to Podocyte Injury in Obesity-Related Glomerulopathy
by: Jing Zhao, et al.
Published: (2019-01-01) -
Corrigendum to “CD36-Mediated Lipid Accumulation and Activation of NLRP3 Inflammasome Lead to Podocyte Injury in Obesity-Related Glomerulopathy”
by: Jing Zhao, et al.
Published: (2019-01-01)